Recruiting Clinical Study of C402-CD19-CAR Treatment in Subjects With Relapsed or Refractory B-cell Lymphoma NCT06830031 Conditions DLBCL, Nos Genetic Subtypes, Dendritic Cell Sarcoma, Interdigitating, Diffuse Large B-cell-lymphoma, +22 more Locations Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences — Tianjin, China View Trial Details
Active, Not Recruiting Venetoclax Plus R-ICE Chemotherapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma NCT03064867 Conditions Dendritic Cell Sarcoma, Interdigitating, Diffuse Large B-cell-lymphoma, Hemic and Lymphatic Diseases, +5 more Locations Washington University School of Medicine, Siteman Cancer Center — St Louis, Missouri, United States University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center — Cleveland, Ohio, United States Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center — Cleveland, Ohio, United States View Trial Details